Literature DB >> 7146319

Haematological studies on 90Sr-90Y-toxicity: II. Femoral CFU-s kinetics and mitogen response of spleen cells.

A F Stevenson, R Daculsi, H Mönig.   

Abstract

Ferrokinetic perturbations in peripheral blood of mice treated with 90Sr-90Y were demonstrated previously. This paper deals with the effects of 90Sr-90Y treatment (2.5, 5, and 10 microCi/mouse), on the haemopoietic stem cell compartment and on the immune-status. The frequency and kinetics of haemopoietic stem cells in femoral marrow (determined as colony forming units in spleen, CFU-s) and their haemopoietic efficiency (as gauged by 59Fe- and 125IUdR-uptake) were estimated. The responsiveness of splenic lymphocytes of the same animals to mitogens (Con A, PHA, and LPS) were also measured. In all assays striking dose-dependent changes marked either by depressions or overshoots were observed during the first week post-incorporation. These are correlated with the pattern of deposition (primary and secondary) of the radionuclides 90Sr-90Y. Towards the end of the period of observation and presumably thereafter, the dependence on dose disappeared and the values remained subnormal. An exception to this was the response of splenic lymphocytes to mitogens. Much higher reactivity was recorded up to the end. This higher reactivity is attributed to augmented cellular turnover, the newly recruited lymphocytes (in accord with thier extreme radiosensitivity), being probably more reactive.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7146319     DOI: 10.1007/bf01323753

Source DB:  PubMed          Journal:  Radiat Environ Biophys        ISSN: 0301-634X            Impact factor:   1.925


  19 in total

1.  The influence of injection route and pH value on the activity ratio of yttrium-90 to strontium-90 in the rat skeleton after 90Sr incorporation.

Authors:  A F Stevenson
Journal:  Health Phys       Date:  1975-11       Impact factor: 1.316

2.  [Distribution of radioyttrium & radioactive rare earths in the mammalian organism. I. Experiments of distribution with carrier-free radioyttrium in guinea pigs].

Authors:  E SPODE
Journal:  Z Naturforsch B       Date:  1958-05       Impact factor: 1.047

3.  The influence of age and sex on the activity ratio of yttrium-90 to strontium-90 in the rat skeleton after incorporation of strontium-90.

Authors:  A F Stevenson
Journal:  Health Phys       Date:  1975-08       Impact factor: 1.316

4.  Some properties of the circulating hemopoietic stem cells.

Authors:  J Gidáli; I Fehér; S Antal
Journal:  Blood       Date:  1974-04       Impact factor: 22.113

5.  Pathologic effects of different doses of radiostrontium imice. Dose effect relationship in 90Sr-induced bone tumours.

Authors:  A Nilsson
Journal:  Acta Radiol Ther Phys Biol       Date:  1970-04

6.  Pathologic effects of different doses of radiostrontium in mice. Changes in the haematopoietic system.

Authors:  A Nilsson
Journal:  Acta Radiol Ther Phys Biol       Date:  1970-12

7.  Temporal and spatial response of marrow colony-forming cells (CFU-s and CFU-c) after 226 Ra incorporation in BALB/c mice.

Authors:  G E Schoeters; O L Vanderborght
Journal:  Radiat Res       Date:  1981-11       Impact factor: 2.841

8.  Hemopoietic spleen colony studies. I. Growth and differentiation.

Authors:  J L Curry; J J Trentin
Journal:  Dev Biol       Date:  1967-05       Impact factor: 3.582

9.  Haematological studies on 90Sr-90Y-toxicity. I. Ferrokinetic changes in peripheral blood of mice.

Authors:  H Mönig; A F Stevenson; I Seiter; K H Steinbach
Journal:  Radiat Environ Biophys       Date:  1980       Impact factor: 1.925

10.  Cyclic erythropoiesis in W/Wv mice following a single small dose of 89Sr.

Authors:  C W Gurney; E L Simmons; E O Gaston
Journal:  Exp Hematol       Date:  1981-02       Impact factor: 3.084

View more
  1 in total

1.  Lymphocyte function following radium-223 therapy in patients with metastasized, castration-resistant prostate cancer.

Authors:  Vahé Barsegian; Stefan P Müller; Daniel Möckel; Peter A Horn; Andreas Bockisch; Monika Lindemann
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-10-08       Impact factor: 9.236

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.